An innovative ethosuximide granule formulation designed for pediatric use: Comparative pharmacokinetics, safety, tolerability, and palatability profile versus reference syrup
Abstract Ethosuximide, the first‐line therapy for childhood absence epilepsy, is currently formulated as a syrup (Zarontin®, Pfizer) with a bitter taste and high sugar content, poorly adapted to children, and a ketogenic diet. The collaborative European FP7 project KIEKIDS aimed at developing an inn...
Wedi'i Gadw mewn:
Prif Awduron: | Léonore Diezi (Awdur), Kim Dao (Awdur), Vincent Jullien (Awdur), Caroline Roussel‐Maupetit (Awdur), Ingrid Burton (Awdur), Pascal André (Awdur), Carine Bardinet (Awdur), Laura E. Rothuizen (Awdur), Haithem Chtioui (Awdur), Maria A. Manso‐Silvan (Awdur), Catherine Guittet (Awdur), Françoise Brunner‐Ferber (Awdur), Francois Vandenhende (Awdur), Catherine Chiron (Awdur), Luc‐André Granier (Awdur), Thierry Buclin (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Wiley,
2023-02-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Ensuring Sufficient Trough Plasma Concentrations for Broad-Spectrum Beta-Lactam Antibiotics in Children With Malignancies: Beware of Augmented Renal Clearance!
gan: Pascal André, et al.
Cyhoeddwyd: (2022) -
Sultiame pharmacokinetic profile in plasma and erythrocytes after single oral doses: A pilot study in healthy volunteers
gan: Kim Dao, et al.
Cyhoeddwyd: (2020) -
Ethosuximide-Induced Pseudolymphoma
gan: J Gordon Millichap
Cyhoeddwyd: (2005) -
Aplastic Anemia with Ethosuximide
gan: J Gordon Millichap
Cyhoeddwyd: (1994) -
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
gan: J Gordon Millichap
Cyhoeddwyd: (2010)